Merck & Co., Inc. Share Price

Equities

MRK

US58933Y1055

Pharmaceuticals

Real-time Estimate Cboe BZX 12:04:34 25/04/2024 am IST 5-day change 1st Jan Change
127.2 USD +0.21% Intraday chart for Merck & Co., Inc. +1.44% +16.65%
Sales 2024 * 63.82B 5,317B Sales 2025 * 68.17B 5,679B Capitalization 321B 26,773B
Net income 2024 * 19.48B 1,623B Net income 2025 * 21.78B 1,814B EV / Sales 2024 * 5.34 x
Net Debt 2024 * 19.65B 1,637B Net Debt 2025 * 7.53B 627B EV / Sales 2025 * 4.83 x
P/E ratio 2024 *
16.4 x
P/E ratio 2025 *
14.3 x
Employees 71,000
Yield 2024 *
2.42%
Yield 2025 *
2.55%
Free-Float 70.75%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.32%
1 week+0.73%
Current month-4.29%
1 month+0.78%
3 months+6.23%
6 months+22.58%
Current year+15.84%
More quotes
1 week
124.50
Extreme 124.5
128.10
1 month
123.77
Extreme 123.77
133.10
Current year
109.16
Extreme 109.16
133.10
1 year
99.14
Extreme 99.14
133.10
3 years
70.89
Extreme 70.89
133.10
5 years
65.25
Extreme 65.25
133.10
10 years
45.69
Extreme 45.69
133.10
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 01/14/01
Director of Finance/CFO 55 01/90/01
Chief Tech/Sci/R&D Officer 55 01/20/01
Members of the board TitleAgeSince
Director/Board Member 63 27/07/27
Director/Board Member 67 01/15/01
Director/Board Member 69 01/18/01
More insiders
Date Price Change Volume
24/24/24 127.2 +0.23% 3 021 084
23/24/23 126.9 -0.05% 7,743,961
22/24/22 126.9 +0.92% 7,805,992
19/24/19 125.8 +0.44% 8,404,345
18/24/18 125.2 -0.11% 5,992,700

Delayed Quote Nyse, April 24, 2024 at 08:38 pm IST

More quotes
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
126.9 USD
Average target price
137.6 USD
Spread / Average Target
+8.43%
Consensus